Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung Cancer

17 Jul 2007

Abstract excerpt

Personalized medicine allows the selection of treatments best suited to an individual patient and disease phenotype. To implement personalized medicine, effective tests predictive of response to treatment or susceptibility to adverse events are needed, and to develop a personalized medicine test, both high quality samples and reliable data are required. We review key features of state-of-the-art proteomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17636986
DOI: 10.1021/pr070046s

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung CancerPMID 17636986Read ↗

Personalized medicine: applying 'omics' to lung fibrosis.Semantic proximity Read ↗

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer managementSemantic proximity Read ↗

Developments for Personalized Medicine of Lung Cancer Subtypes: Mass Spectrometry-Based Clinical Proteogenomic Analysis of Oncogenic Mutations.Semantic proximity Read ↗

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerSemantic proximity Read ↗

Identification of promising lung cancer drug targets from human plasma proteins: Mendelian randomization, single-cell RNA sequencing analysisSemantic proximity Read ↗

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read ↗

Pharmacogenomic biomarkers for personalized cancer treatment.Semantic proximity Read ↗

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancerSemantic proximity Read ↗

Personalized Medicine and CancerSemantic proximity Read ↗

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaSemantic proximity Read ↗

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applicationsSemantic proximity Read ↗

Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.